Early use of continuous glucose monitoring in children and adolescents after total pancreatectomy with islet autotransplantation

Autor: Neha Potlapalli, Varvara A. Kirchner, Kendall R. McEachron, Melena D. Bellin, Sarah Jane Schwarzenberg, Arpana Rayannavar, Gregory J. Beilman, Srinath Chinnakotla, Elissa M. Downs
Rok vydání: 2020
Předmět:
Male
Pediatrics
medicine.medical_specialty
endocrine system diseases
Adolescent
Total pancreatectomy
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Islets of Langerhans Transplantation
030209 endocrinology & metabolism
Pilot Projects
Glycemic Control
Transplantation
Autologous

03 medical and health sciences
0302 clinical medicine
Pancreatectomy
Diabetes management
Pancreatitis
Chronic

Internal Medicine
medicine
Humans
030212 general & internal medicine
Child
Glycemic
geography
geography.geographical_feature_category
Continuous glucose monitoring
business.industry
Insulin
Blood Glucose Self-Monitoring
nutritional and metabolic diseases
Islet
medicine.disease
Autotransplantation
Patient Satisfaction
Pediatrics
Perinatology and Child Health

Pancreatitis
Feasibility Studies
Female
business
Zdroj: Pediatric diabetesREFERENCES. 22(3)
ISSN: 1399-5448
Popis: Background Children undergoing total pancreatectomy with islet autotransplantation (TPIAT) for chronic pancreatitis require intensive insulin therapy early after TPIAT with narrow glycemic targets, which can a present significant care burden. Outpatient use of continuous glucose monitoring (CGM) systems by children and caregivers early after TPIAT is inadequately studied. Methods In this open-label study, we randomized 14 children and adolescents (mean age 15.4 years) after hospital discharge for TPIAT to Dexcom G6 CGM (n = 7) or standard care with a glucometer (n = 7) to assess acceptability and glycemic control with use of CGM versus usual care (glucometer). Participants in the control arm also wore a blinded CGM for 1 week. Result Children randomized to real-time CGM had lower mean sensor glucose values compared with controls (p = 0.002), and high overall satisfaction with CGM. Conclusions Our data indicate that CGM is a useful adjunct to diabetes management for children who have recently undergone TPIAT.
Databáze: OpenAIRE